Common Contracts
3 similar Employment Agreement contracts by Jounce Therapeutics, Inc.
Amendment No. 1 to Amended and Restated Employment AgreementEmployment Agreement • February 23rd, 2023 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 1 to the Amended and Restated Employment Agreement (this “Amendment No. 1”), effective January 27, 2023 (the “Amendment No. 1 Effective Date”), is made and entered into by and between Jounce Therapeutics, Inc., a Delaware corporation (“Jounce”), and Kim C. Drapkin (the “Executive”).
Amendment No. 1 to Amended and Restated Employment AgreementEmployment Agreement • February 23rd, 2023 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 1 to the Amended and Restated Employment Agreement (this “Amendment No. 1”), effective January 27, 2023 (the “Amendment No. 1 Effective Date”), is made and entered into by and between Jounce Therapeutics, Inc., a Delaware corporation (“Jounce”), and Elizabeth Trehu, M.D. (the “Executive”).
Amendment No. 1 to Amended and Restated Employment AgreementEmployment Agreement • February 23rd, 2023 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 1 to the Amended and Restated Employment Agreement (this “Amendment No. 1”), effective January 27, 2023 (the “Amendment No. 1 Effective Date”), is made and entered into by and between Jounce Therapeutics, Inc., a Delaware corporation (“Jounce”), and Richard Murray, Ph.D. (the “Executive”).
